Asset Management Company — 2007 Investments

1 investments dated 2007 · listed companies and verified rows first · show all

BiPar Sciencessanofi.us inFeb 2007Acquired

Biopharmaceutical developer of tumor-selective PARP inhibitor cancer therapies, acquired by Sanofi-aventis in 2009.

Co-investorsAisling Capital Canaan Partners Kleiner Perkins SPRINGROCK VENTURES VantagePoint Capital Partners Domain Associates

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.